FDA Announces New Meetings, Workshops

The US Food and Drug Administration (FDA) announced three new advisory committee meetings and a new workshop in the Federal Register on 23 May 2012. Regulatory Focus is pleased to present you with a brief summary of their respective topics.

Meeting: Oncologic Drugs Advisory Committee
The committee will discuss and provide general advice on the extent to which, if any, the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information.

Meeting: Risk Communication Advisory Committee
This meeting will discuss how patients perceive, communicate and understand risk when they are facing multiple risks.

Meeting: Requirements for Importing FDA Regulated Products into the US
This meeting will discuss FDA regulations with respect to importing pharmaceutical products, medical devices and other technologies into the US, and the involvement of brokers and forwarders in the importation process.

Public Workshop: Use of Computer Simulation of the US Blood Supply in Support of Planning for Emergency Preparedness and Medical Countermeasures
This workshop aims to discuss the possible applications of an FDA computer simulation model of the US' blood supply during an emergency, the weaknesses and strengths of the model, how to enhance the model, and the development of plausible scenarios to test the model.